€0.19
-3.05%
Compare
VVisiomed Group SA vs EssilorLuxotticaEVVisiomed Group SA vs Sartorius StedimSVVisiomed Group SA vs Crossject S.ACVVisiomed Group SA vs Spineway S.ASVVisiomed Group SA vs Bonyf N.VBVVisiomed Group SA vs CAC 40 | MarketC

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 36.6M
Total Liabilities 11.8M
Shareholders Equity 24.7M
Debt to Equity 0.48

Cash Flow Metrics

Revenue & Profitability Trend

Annual Income Flow i

Visiomed Group SA Income Statement From 2020 to 2023

Metric 2023 2022 2021 2020
Revenue i 13.7M 14.4M 7.2M 19.0M
Cost of Goods Sold i 7.4M 11.2M 7.9M 22.7M
Gross Profit i 6.3M 3.2M -715.0K -3.8M
Gross Margin % i 46.0% 22.2% -10.0% -19.8%
Operating Expenses
Research & Development i - - - -
Selling, General & Administrative i - - - -
Other Operating Expenses i 23.0K 801.0K 832.0K -786.0K
Total Operating Expenses i 23.0K 801.0K 832.0K -786.0K
Operating Income i 952.0K -3.9M -3.7M -6.6M
Operating Margin % i 6.9% -27.1% -51.3% -34.8%
Non-Operating Items
Interest Income i 112.0K 4.0K 12.0K -
Interest Expense i 1.2M 182.0K 618.0K 382.0K
Other Non-Operating Income - - - -
Pre-tax Income i 1.5M -5.1M -4.2M -5.2M
Income Tax i -37.0K 113.0K 142.0K -164.0K
Effective Tax Rate % i -2.4% 0.0% 0.0% 0.0%
Net Income i 902.0K -5.3M -4.5M -5.2M
Net Margin % i 6.6% -36.5% -62.1% -27.1%
Key Metrics
EBITDA i 4.2M -1.2M -2.9M -6.7M
EPS (Basic) i €0.00 €-0.02 €-0.03 €-0.20
EPS (Diluted) i €0.00 €-0.02 €-0.03 €-0.20
Basic Shares Outstanding i 294356419 263850000 138087389 25382874
Diluted Shares Outstanding i 294356419 263850000 138087389 25382874

Income Statement Trend

Visiomed Group SA Balance Sheet From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Assets
Current Assets
Cash & Equivalents i 3.0M 2.4M 6.6M 779.0K -
Short-term Investments i - - 7.0K 31.0K 415.0K
Accounts Receivable i 1.2M 1.8M 4.6M 252.0K -
Inventory i 0 658.0K 1.4M 1.3M -
Other Current Assets - 410.0K 203.0K 330.0K -1.0K
Total Current Assets i 5.3M 7.0M 16.0M 5.1M -
Non-Current Assets
Property, Plant & Equipment i 7.3M 13.0M 8.5M 1.0M -
Goodwill i 49.5M 38.3M 44.1M 541.0K -
Intangible Assets i 356.0K 374.0K 90.0K 97.0K -
Long-term Investments - - - - -
Other Non-Current Assets 1.0K -1.0K -101.0K 1.0K -
Total Non-Current Assets i 31.3M 29.1M 28.1M 832.0K -
Total Assets i 36.6M 36.1M 44.1M 5.9M -
Liabilities
Current Liabilities
Accounts Payable i 2.1M 3.0M 17.3M 5.2M -
Short-term Debt i 287.0K 127.0K 0 2.0K -
Current Portion of Long-term Debt - - - - -
Other Current Liabilities - 310.0K 13.0M 69.0K 38.0K
Total Current Liabilities i 3.4M 5.5M 19.3M 8.8M -
Non-Current Liabilities
Long-term Debt i 7.6M 5.5M 5.0M 13.0K -
Deferred Tax Liabilities i - - - - -
Other Non-Current Liabilities -1.0K -1.0K 1.2M 406.0K -
Total Non-Current Liabilities i 8.5M 6.3M 10.7M 1.5M -
Total Liabilities i 11.8M 11.8M 30.0M 10.3M -
Equity
Common Stock i 2.9M 2.9M 1.4M 20.3M -
Retained Earnings i 902.0K -5.3M -4.5M -36.7M -
Treasury Stock i - - - - -
Other Equity - - - - -
Total Shareholders Equity i 24.7M 24.3M 14.1M -4.4M -
Key Metrics
Total Debt i 7.9M 5.6M 5.0M 15.0K 0
Working Capital i 1.9M 1.5M -3.3M -3.7M 0

Balance Sheet Composition

Visiomed Group SA Cash Flow Statement From 2020 to 2023

Metric 2023 2022 2021 2020
Operating Activities
Net Income i 902.0K -5.3M -4.5M -5.2M
Depreciation & Amortization i - - - -
Stock-Based Compensation i - - - -
Working Capital Changes i 0 0 0 0
Operating Cash Flow i -1.3M -5.3M -4.5M -5.2M
Investing Activities
Capital Expenditures i -1.8M -5.5M -171.0K 3.1M
Acquisitions i - - - -
Investment Purchases i - - - -
Investment Sales i - - - -
Investing Cash Flow i -1.6M -17.5M -15.0M 3.1M
Financing Activities
Share Repurchases i - - - -
Dividends Paid i - - - -
Debt Issuance i 2.4M 12.2M 26.0M 1.6M
Debt Repayment i -1.3M -650.0K -713.0K -1.6M
Financing Cash Flow i 1.0M 14.8M 27.2M 0
Free Cash Flow i -1.5M -7.3M -6.7M -11.1M
Net Change in Cash i -1.8M -8.0M 7.7M -2.1M

Cash Flow Trend

Visiomed Group SA Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 59.67
Forward P/E 5.75
Price to Sales 3.85

Profitability Ratios

Profit Margin 45.95%
Operating Margin 19.87%
Return on Equity 3.64%
Return on Assets 2.46%

Financial Health

Current Ratio 1.56
Debt to Equity 0.32

Per Share Data

EPS (TTM) €0.00
Revenue per Share €0.05

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
ALVMG 52.8M 59.67 - 3.64% 45.95% 0.32
Sartorius Stedim 15.8B 59.45 3.86 6.59% 8.98% 63.11
Crossject S.A 105.6M - - 212.74% 0.00% -4.61
Spineway S.A 5.8M 16.20 0.25 -9.46% -17.47% 6.63
Bonyf N.V 2.5M - 5.72 -32.61% 8.02% 0.00
Nippun Rana

Nippun Rana

Chasing the market trend!

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, an...

Financial data is updated regularly. All figures are in the company's reporting currency.